Tranzyme , Nasdaq: TZYM
Developing small molecule therapeutics to treat gastrointestinal disorders.
Industry: Health Care
First Day Return: 0.0%
| IPO Data | |
|---|---|
| IPO Date | 04/01/2011 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $54 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Durham, NC, United States |
| Founded | 1998 |
| Employees at IPO | 39 |
| Website www.tranzyme.com | |
Tranzyme (TZYM) Performance
